![]() |
|||||||||||||
| e.IP | Electrophysiology | Innovations | Events | News | Jobs | Links | |||||||||||||
| About e.IP |
Multi Channel Systems MCS GmbH - company directory
Multi Channel Systems (MCS) was founded in 1996 and is located in Reutlingen,
Germany. The company has evolved as one of the market-leaders of sophisticated
products and high-speed data acquisition in the in vitro and in vivo field
of "Neuro-Electronics". The Roboocyte®: Secondary functional screening is often hampered by the lack of throughput
capacity. Even advanced electrophysiological methods necessite the need
for highly trained personnel and time-consuming experiments. Thus automated
and robotic systems are in need to compensate for the discrepancy in throughput
between high-throughput-screening (HTS) and subsequent stages in successful
drug screening and development. Multi-Electrode-Arrays: MCS offers a wide variety of Multi- Electrode Arrays with different electrode characteristics, electrode spacing and layout configurations to satisfy every users need, might it be single-cell or filed potential recordings in cultured cells, organotypic slices, and acute slice preparations. Amplifiers: The MEA1060 is a 60 channel in vitro amplifier and compatible with all
different MEA´s. It is a sophisticated SMD-based filter amplifier
and easy to use. Stimulators: The STG- series of stimulators come in a 1,2, 4, or 8 channel version. Current or voltage stimulation pulses can be applied either as a simple square, a sine wave, a ramp, or even as an arbitrary waveform via ASCII upload. Stimulus paradigms can be easily edited via the Windows-based MC_Stimulus software and downloaded via a fast serial port. The key feature of the STG-series is the built-in stimulus-isolation-unit. Thus direct output of the current and voltage values is permitted without the need of additional isolation units. Our vision Multi Channel Systems engages in the development of automated multi-channel
measurements in basic research and in pharmaceutical screening. We are
actively seeking product solutions to bridge the gap between the ever
expanding number of compound hits obtained by high-throughput-screening
and the lack of fast secondary functional screening methods. |
||||||||||||